Yup a significant increase in sales will provide some surety for the company. Our cash burn is very conservative and it’s not out of the question to almost cover the burn in a year or so if we get the right customer base happening.
Then we can but cross our fingers with progress on the others. Neuronet and the treatment of solid cancers are very exciting prospects.
- Forums
- ASX - By Stock
- IIQ
- IIQ General Discussion
IIQ General Discussion, page-233
Featured News
Add IIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.18M |
Open | High | Low | Value | Volume |
45.0¢ | 45.0¢ | 43.0¢ | $18.17K | 41.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 52546 | 43.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 24522 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 52546 | 0.435 |
2 | 6333 | 0.430 |
5 | 44773 | 0.425 |
1 | 10000 | 0.410 |
3 | 24814 | 0.405 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 24522 | 1 |
0.460 | 6850 | 1 |
0.465 | 1195 | 1 |
0.470 | 35663 | 2 |
0.480 | 40000 | 2 |
Last trade - 13.54pm 12/11/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online